Search clinical trials for: ABY-029

Total 9443 results

Suzhou Municipal Hospital of Anhui Province
Xuanwu Hospital, Beijing

Recruiting

Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment (IRIS)

Ischemic Stroke | Endovascular Treatment | Interleukin-6

China
University Hospital, Strasbourg, France

Completed

Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study (PlasmaFaisa)

Septic Shock | Coagulopathy | Disseminated Intravascular Coagulation

France
Alteogen, Inc.

Completed

Clinical Study of ALT-BB4 to Determine Tolerance, Safety and Pharmacokinetics in Healthy Volunteer

Health, Subjective

Korea, Republic of
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

China
Eli Lilly and Company

Completed

A Study of Single and Repeated Doses of LY3556050 in Healthy Participants

Healthy

United States
Ain Shams University

Active, not recruiting

Ratio of ''Central Venous-to-Arterial Co2 Gap'' to ''Arterial-to-Central Venous O2 Content Gap'' in Septic Shock

Septic Shock

Egypt
GTx

Completed

Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence (ASTRID)

Stress Urinary Incontinence

United States
Arch Biopartners Inc.

Completed

A Phase I Study to Evaluate LSALT Peptide

None - Study is to Determine Safety in Healthy Participants

Australia
GlaxoSmithKline

Completed

A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers

Diabetes Mellitus, Type 2

United States
Nantes University Hospital

Completed

Continuous Regional Analgesia After Total Knee Arthroplasty

Analgesia

France
Aadi Bioscience, Inc.

Recruiting

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

Neuroendocrine Tumors | Pancreatic Neuroendocrine Tumor | Gastrointestinal Neuroendocrine Tumor | NET | Pulmonary Neuroendocrine Tumor

United States
University of Padova
University of Florence

Completed

Safe Delivery Using a Belt on the Belly of Pregnant Woman (SDB)

Other Obstetric Trauma - Delivered

Italy
NovaRock Biotherapeutics, Ltd

Recruiting

A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.

Advanced Malignant Tumors

China
Imperial College London

Completed

RAS and Coagulopathy in COVID19

COVID

United Kingdom
Second Affiliated Hospital, School of Medicine,...
Second Affiliated Hospital of Wenzhou Medical University; Zhejiang University; Red Cross Hospital, Hangzhou, China and other collaborators

Terminated

Efficacy and Safety of Salvianolic Acid on AIS

Stroke

China
Travere Therapeutics, Inc.

Terminated

Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants (PKAN)

Pantothenate Kinase-Associated Neurodegeneration

United States, Canada, Czechia, France, Germany, Italy, Norway, Poland, Spain
HanAll BioPharma Co., Ltd.

Completed

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

United States
Hospital Universitari Vall d'Hebron Research Institute

Completed

Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis (ALFAE)

Hepatic Encephalopathy

Spain
Biocad

Completed

The BCD-089 (aIL6R) in Patients With Active Rheumatoid Arthritis (AURORA)

Seropositive RA

Russian Federation, Belarus
Innovaderm Research Inc.
Merck Sharp & Dohme LLC

Terminated

Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

Psoriasis

Canada
AbbVie

Completed

The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4) (ENDURANCE-4)

Hepatitis C Virus
Aadi Bioscience, Inc.

Completed

A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa (AMPECT)

Malignant PEComa

United States
Aadi Bioscience, Inc.

Active, not recruiting

ABI-009, an mTOR Inhibitor, for Patients With Severe Pulmonary Arterial Hypertension

Pulmonary Hypertension

United States
Tehran University of Medical Sciences
Tehran Heart Center

Completed

Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN)

Contrast Induced Nephropathy

Iran, Islamic Republic of
Pierre Van Damme

Completed

A Study to Assess the Acceptability and Usability of a New Device for Intradermal Vaccination

Pain | Vaccination Adverse Event

Belgium
University of Campania "Luigi Vanvitelli"
University of Bologna; University of Rome Tor Vergata; Italian Group for the...

Recruiting

Fertility and Pregnancy After Surgery IBD Audit (Fertile-IBD)

Inflammatory Bowel Diseases | Pregnancy Complications | Crohn Disease | Ulcerative Colitis | Fertility Disorders | Delivery Problem

Italy
Antalya Bilim University

Completed

The Effects of Mother-Baby Yoga and Baby Massage on Attachment and Sleep

Sleep | Yoga | Newborn | Mother-Infant Interaction

Turkey
Johnson & Johnson Consumer Inc. (J&JCI)

Terminated

A Study of a Baby Wash/Shampoo and Baby Lotion Versus Baby Wash/Shampoo Alone for Impact on Skin Barrier and Microbiome on Newborns

Healthy

United States
University of California, Los Angeles

Completed

Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD) (BabyJ)

Children at Risk for ASD

United States
University of California, Davis
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis

Diabetic Ketoacidosis | Cerebral Edema

United States
University of New Mexico

Completed

Fluid Chloride and AKI in Cardiopulmonary Bypass

Acute Kidney Injury

United States
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection (ENDURANCE-2)

Chronic Hepatitis C Virus (HCV) Infection
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection (EXPEDITION-4)

Chronic Hepatitis C Virus (HCV) Infection
AbbVie (prior sponsor, Abbott)

Completed

A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention-Deficit/Hyperactivity Disorder

United States
Abalonex, LLC

Not yet recruiting

Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury

Traumatic Brain Injury | Cerebral Edema
Active Biotech AB

Completed

Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

Denmark, Sweden
University of Edinburgh
NHS Lothian

Completed

Intraoperative Cell Salvage and Postoperative Acidosis

Metabolic Acidosis

United Kingdom
GTx

Withdrawn

Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence

Stress Urinary Incontinence

United States
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)

United States, Australia, Brazil, Italy, United Kingdom
ArQule, Inc. (a wholly owned subsidiary of Merck...
Worldwide Clinical Trials

Terminated

Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome (MOSAIC) (MK-7075-002) (MOSAIC)

PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome

United States, Australia, Italy, Spain
Maternal and Child Health Hospital of Foshan

Withdrawn

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars

Uterine Scar

China
Synthetic Biologics Inc.
Spaulding Clinical Research LLC

Completed

Multiple Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered SYN 020

Enteritis Caused by Radiation

United States
Five Eleven Pharma, Inc.

Completed

Initial Investigation of [18F]P16-129 in Alzheimer's Disease Patients and Healthy Volunteers

Alzheimer Disease

United States
Vasopharm GmbH

Completed

Phase 2 a Study to Assess Safety and Pharmacokinetics of VAS203 in Patients With Traumatic Brain Injury (NOSTRA)

Traumatic Brain Injury

Austria, France, Spain, Switzerland, United Kingdom
Solasia Pharma K.K.

Completed

A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL)

Peripheral T-cell Lymphoma

Japan
Fab'entech

Completed

Safety and Pharmacokinetics Study of FBF001

Avian Influenza
Pacira Pharmaceuticals, Inc

Completed

Study of Pain Control in Hemorrhoidectomy

Hemorrhoid

Poland
Plotnikoff, Gregory A., M.D.
University of Minnesota; Tsumura and Company, Tokyo, Japan

Completed

TU 025 Keishi Bukuryo Gan for Post-menopausal Hot Flash Management

Hot Flashes | Menopause

United States
University Hospital Birmingham NHS Foundation Trust

Unknown

Nitrite Mediated Cardioprotection During Coronary Artery Bypass Surgery

Coronary Artery Bypass Surgery

United Kingdom
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) (EXPEDITION-2)

Hepatitis C Virus Infection | Chronic Hepatitis C | Human Immunodeficiency Virus Infection | Compensated Cirrhosis and Non-cirrhotics

Search clinical trials for: ABY-029

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations